Cover Image


Gene Editing: CRISPR/Cas9 Changes Everything

出版商 Strategic Directions International, Inc. 商品編碼 648167
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
Back to Top
改變遺傳基因編輯:全部的CRISPR/Cas9 Gene Editing: CRISPR/Cas9 Changes Everything
出版日期: 2016年01月22日 內容資訊: 英文



  • 簡介
  • 技術概要
    • 遺傳基因編輯
    • 實行技術
  • 主要的產品概要
    • CRISPR
    • TALEN
    • 鋅指核酸酶 (ZFN)
  • 市場需求預測
    • 整體市場
    • 遺傳基因編輯化驗
    • 實行技術
  • 未來展望


  • Addgene
  • Agilent
  • Allele Biotech
  • Bio-Rad
  • Clontech
  • DNA 2.0
  • GE Healthcare
  • GeneCopoeia
  • GenScript
  • IDT
  • Lonza
  • Merck KgaA
  • New England Bioscience
  • Origene
  • Promega
  • Qiagen
  • Roche
  • Santa Cruz Biotechnology
  • Sigma-Aldrich
  • System Biosciences
  • Taconic Biosciences
  • Thermo Fisher Scientific
  • Transposagen Biopharmaceuticals
Product Code: 16-400

This Market Brief is intended to provide a snapshot of the gene editing market for 2015-2020. As such, the information provided can be an important market reference aid for understanding the dynamics of this particular market segment.

Gene editing is a type of genetic engineering. Technologies used to accomplish this are Clustered Regularly-Interspaced Short Palindromic Repeats (CRISPR), Transcription Activator-Like Effector Nucleases (TALEN), Zinc-Finger Nucleases (ZFN), among others.

CRISPR is a disruptive gene editing methodology that has invigorated the genomics market, taking life science research to another level of innovation. With explosive growth, the technology is not only creating opportunities in genetic engineering, but it is fueling growth for enabling technologies such as next-generation sequencing (NGS), PCR, lab automation, microarrays, nucleic acid prep kits, flow cytometry, and high content analysis/imaging, that play key roles in preparation, transfection and cell ID/confirmation.

This report provides information on the total gene editing market including enabling technologies. It measures the market size ($millions) for 2015 and forecasts five-year growth to 2020 in terms of workflow, product type, geography and application. Vendor share is provided for the gene editing segment (i.e. CRISPR, ZFN, TALEN).

Table of Contents

Part I. Gene Editing Market Brief

  • A. Introduction
  • B. Technology Overview
    • 1.Gene Editing
    • 2. Enabling Technologies
  • C. Select Products Descriptions
    • 1. CRISPR
    • 2. TALEN
    • 3. Zinc Finger Nuclease (ZFN)
  • D. Market Demand (2015-2020)
    • 1. Overall Gene Editing Market
    • 2. Gene Editing Assays
    • 3. Enabling Technologies
  • E. Future Prospects

Part II. Company Descriptions

  • A. Addgene
  • B. Agilent
  • C. Allele Biotech
  • D. Bio-Rad
  • E. Clontech
  • F. DNA 2.0
  • G. GE Healthcare
  • H. GeneCopoeia
  • I. GenScript
  • J. IDT
  • K. Lonza
  • L. Merck KgaA
  • M. New England Bioscience
  • N. Origene
  • O. Promega
  • P. Qiagen
  • Q. Roche
  • R. Santa Cruz Biotechnology
  • S. Sigma-Aldrich
  • T. System Biosciences
  • U. Taconic Biosciences
  • V. Thermo Fisher Scientific
  • W. Transposagen Biopharmaceuticals
Back to Top